IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Skywatcher who wrote (1688)	9/9/1999 12:28:00 PM
From: Just_Observing	Read Replies (1) of 1762

Apparently dropping because of CEO comments that expectations are too high for this quarter. He said that expectations of 80 million in sales this quarter are too high for their Lymphoma drug (Rituxin ?? sorry got name on phone so spelling may not be right). Merrill had been touting this stock as one that would blow away expectations. In any case, Merrill came out and reiterated a buy at 112. This should provide support. Good Luck and Best Wishes

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next